Cytovia Therapeutics Overview

  • Status
  • Out of Business

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 10

  • Investments
  • 2

Cytovia Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to address several of the unmet medical needs in oncology. The company's bio-medicines and drugs include a patented drug screening technology that discovers and develops small-molecule inhibitors and activators of capsules, enabling patients to fight cancer through stem cell engineering and multispecific antibodies.

Contact Information

Formerly Known As
Cytovia Holdings, Inc.
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Corporate Office
  • 18851 Northeast 29th Avenue
  • 2nd Floor
  • Aventura, FL 33180
  • United States
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 18851 Northeast 29th Avenue
  • 2nd Floor
  • Aventura, FL 33180
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytovia Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cytovia Therapeutics‘s full profile, request access.

Request a free trial

Cytovia Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytovia Therapeutics Investments (2)

Cytovia Therapeutics’s most recent deal was a Joint Venture with CytoLynx Therapeutics for . The deal was made on 13-Sep-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CytoLynx Therapeutics 13-Sep-2021 Joint Venture Biotechnology
CytoImmune Therapeutics (Worldwide Rights for Novel EGFR Dual-targeting CAR) 03-Aug-2020 Corporate Asset Purchase Buildings and Property
To view Cytovia Therapeutics’s complete investments history, request access »

Cytovia Therapeutics FAQs

  • Where is Cytovia Therapeutics headquartered?

    Cytovia Therapeutics is headquartered in Aventura, FL.

  • What is the size of Cytovia Therapeutics?

    Cytovia Therapeutics has 18 total employees.

  • What industry is Cytovia Therapeutics in?

    Cytovia Therapeutics’s primary industry is Biotechnology.

  • Is Cytovia Therapeutics a private or public company?

    Cytovia Therapeutics is a Private company.

  • What is Cytovia Therapeutics’s current revenue?

    The current revenue for Cytovia Therapeutics is .

  • How much funding has Cytovia Therapeutics raised over time?

    Cytovia Therapeutics has raised $5.3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process